These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23789754)

  • 21. Carvedilol stability in paediatric oral liquid formulations.
    Buontempo F; Bernabeu E; Glisoni RJ; Quiroga E; Bregni C; Chiappetta DA
    Farm Hosp; 2010; 34(6):293-7. PubMed ID: 20418137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Nguyen AT; Miller V; Morris TC; Graves RA
    Int J Pharm Compd; 2019; 23(1):70-76. PubMed ID: 30668538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and stability evaluation of extemporaneous oral suspension of valsartan using commercially available tablets.
    Zaid AN; Assali M; Qaddomi A; Ghanem M; Zaaror YA
    Int J Pharm Compd; 2014; 18(2):169-74. PubMed ID: 24881122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of extemporaneously prepared rufinamide oral suspensions.
    Hutchinson DJ; Liou Y; Best R; Zhao F
    Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical and microbiological stability studies of extemporaneous antihypertensive pediatric suspensions for hospital use.
    Mendes C; Costa AP; Oliveira PR; Tagliari MP; Silva MA
    Pharm Dev Technol; 2013; 18(4):813-20. PubMed ID: 22670721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Kader C; Morris TC; Graves RA
    Int J Pharm Compd; 2021; 25(5):431-439. PubMed ID: 34623970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Kader C; Morris TC; Graves RA
    Int J Pharm Compd; 2022; 26(4):342-351. PubMed ID: 35820140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The stability of quetiapine oral suspension compounded from commercially available tablets.
    Tran J; Gervase MA; Evans J; Deville R; Dong X
    PLoS One; 2021; 16(8):e0255963. PubMed ID: 34375349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of sulfadiazine oral liquids prepared from tablets and powder.
    Pathmanathan U; Halgrain D; Chiadmi F; Schlatter J; Vermerie N
    J Pharm Pharm Sci; 2004 Apr; 7(1):84-7. PubMed ID: 15144740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days.
    Svirskis D; Jaffer J; Agarwal P; Khan A; Kaur J; Cheng A; Hanning S
    Int J Pharm Compd; 2020; 24(3):246-251. PubMed ID: 32401745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of Prednisone in Oral Mix Suspending Vehicle.
    Friciu M; Plourde K; Leclair G; Danopoulos P; Savji T
    Int J Pharm Compd; 2015; 19(4):337-9. PubMed ID: 26625571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of extemporaneous pediatric oral liquids compounded from tablets and drug substance: case of propranolol and theophylline.
    Muśko M; Sznitowska M
    Acta Pol Pharm; 2013; 70(1):137-45. PubMed ID: 23610969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation.
    Garg A; Garg S; She RW
    Burns; 2011 Nov; 37(7):1150-3. PubMed ID: 21764219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets.
    Jarouche M; Ibrahim M; Pearson J; Low M; Rowe J
    Int J Pharm Compd; 2020; 24(1):77-82. PubMed ID: 32023219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base.
    Spennacchio A; Lopedota A; la Forgia F; Fontana S; Franco M; Denora N
    Int J Pharm Compd; 2023; 27(1):72-77. PubMed ID: 36720064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding.
    Rush SD; Vernak C; Zhao F
    Int J Pharm Compd; 2017; 21(1):83-87. PubMed ID: 28346201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of three commonly compounded extemporaneous enrofloxacin suspensions for oral administration to exotic animals.
    Petritz OA; Guzman DS; Wiebe VJ; Papich MG
    J Am Vet Med Assoc; 2013 Jul; 243(1):85-90. PubMed ID: 23786194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms.
    Stanisz BJ; Paszun SK; Zalewska A
    Acta Pol Pharm; 2014; 71(4):661-6. PubMed ID: 25272892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.